ATC
BMY.RT

Argent Trust Co’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Argent Trust Co’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,019
Closed -$8K – 490
2020
Q4 		$8K Sell
12,019
-178
-1% -$379 ﹤0.01% 462
2020
Q3 		$27K Sell
12,197
-15
-0.1% -$43 ﹤0.01% 444
2020
Q2 		$44K Sell
12,212
-338
-3% -$1.22K ﹤0.01% 437
2020
Q1 		$48K Sell
12,550
-733
-6% -$2.42K 0.01% 409
2019
Q4 		$40K Buy
+13,283
New +$34.5K ﹤0.01% 462

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Argent Trust Co's BMY.RT Position: Q1 2021 in Review

Argent Trust Co sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 12,019 shares — an estimated $8K sold.

Argent Trust Co first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $48K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Argent Trust Co reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Argent Trust Co sold 12,019 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $8K.
  • Argent Trust Co first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Argent Trust Co's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $48K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Argent Trust Co's 13F filing for Q1 2021, filed 12 May 2021.